News Indivior stops Opvee promotion in New York after settlement Indivior has agreed to halt all marketing of its opioid overdose drug Opvee in New York after being rapped for mispromoting it to health officials.
News Leaked MAHA draft signposts US health reform under Trump A leaked version of the Make America Healthy Again programme for the Trump administration has plenty for the pharma industry to stew over.
Sales & Marketing Big Pharma borrows a page from pro athletes' marketing playb... Explore how athletes leverage data and DTC marketing, and learn how Big Pharma is borrowing from their successful playbook.
News UK authority cracks down on weight-loss drug ads Nine adverts for weight-loss services have been banned by the Advertising Standards Authority in the UK for promoting prescription-only drugs.
News US lawmakers seek ban on DTC advertising US Senators Bernie Sanders and Angus King have introduced a bill that seeks to ban direct-to-consumer (DTC) advertising by the pharma industry.
Sales & Marketing The 2025 way forward: What can UK healthcare advertising exp... Buoyed by growth opportunities and the strengthening economy, 2024 turned out to be an interesting year for the United Kingdom’s (UK) healthcare advertising industry.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.